Literature DB >> 12966539

HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma.

Anders Malmsten1, Xing-Wu Shao, Kajsa Aperia, Gary E Corrigan, Eric Sandström, Clas F R Källander, Thomas Leitner, J Simon Gronowitz.   

Abstract

We describe a procedure (ExaVir Load) to carry out human immunodeficiency virus-1 (HIV-1) viral load testing using reverse transcriptase (RT) recovered from HIV-1 virions in plasma. Samples from individuals infected with HIV-1 were treated with a sulphydryl-reactive agent to inactivate endogenous polymerases. Virions were then immobilised on a gel and washed in individual mini columns to remove RT-inhibiting antibodies, antiviral drugs, and other RT inhibitors. Immobilised virions were lysed finally, and the viral RT eluted. The amount of RT recovered was quantified by a sensitive RT activity assay using either colorimetry or fluorimetry to detect DNA produced by RT. The "RT load" values of 390 samples from 302 HIV-1 patients living in Sweden were compared to results obtained with an HIV-1 RNA viral load assay. The correlation between the two tests was r = 0.90, P < 0.0001. Four of 202 samples from healthy blood donors gave low positive values in the RT test. All samples in a panel with 10 HIV-1 subtypes were positive by the RT load. The RT load test provides a technically less demanding and cost-effective alternative to methods based on nucleic acid amplification. Being insensitive to genetic drift occurring in HIV, the assay should be of particular use in resource-limited settings, where different subtypes and recombinant HIV strains occur. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966539     DOI: 10.1002/jmv.10492

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.

Authors:  Vicki L Greengrass; Megan M Plate; Pauline M Steele; Justin T Denholm; Catherine L Cherry; Lisa M Morris; Anna Hearps; Suzanne M Crowe
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

2.  Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings.

Authors:  Sumathi Sivapalasingam; Shaffiq Essajee; Phillipe N Nyambi; Vincenza Itri; Bruce Hanna; Robert Holzman; Fred Valentine
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Authors:  Francois Rouet; Didier K Ekouevi; Marie-Laure Chaix; Marianne Burgard; Andre Inwoley; Thomas D'Aquin Tony; Christine Danel; Xavier Anglaret; Valeriane Leroy; Philippe Msellati; Francois Dabis; Christine Rouzioux
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay.

Authors:  Cheryl Jennings; Susan A Fiscus; Suzanne M Crowe; Aleksandra D Danilovic; Ralph J Morack; Salvatore Scianna; Ada Cachafeiro; Donald J Brambilla; Jorg Schupbach; Wendy Stevens; Richard Respess; Oliviero E Varnier; Gary E Corrigan; J Simon Gronowitz; Michael A Ussery; James W Bremer
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.

Authors:  Paul Stewart; Ada Cachafeiro; Sonia Napravnik; Joseph J Eron; Ian Frank; Charles van der Horst; Ronald J Bosch; Daniel Bettendorf; Peter Bohlin; Susan A Fiscus
Journal:  J Clin Virol       Date:  2010-09-15       Impact factor: 3.168

Review 6.  Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.

Authors:  Paul K Drain; Jienchi Dorward; Andrew Bender; Lorraine Lillis; Francesco Marinucci; Jilian Sacks; Anna Bershteyn; David S Boyle; Jonathan D Posner; Nigel Garrett
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

Review 7.  Advances in developing HIV-1 viral load assays for resource-limited settings.

Authors:  ShuQi Wang; Feng Xu; Utkan Demirci
Journal:  Biotechnol Adv       Date:  2010-07-01       Impact factor: 14.227

8.  Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.

Authors:  Lucie Etienne; Sabrina Eymard-Duvernay; Avelin Aghokeng; Christelle Butel; Marjorie Monleau; Martine Peeters
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

9.  HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays.

Authors:  Sonia Napravnik; Ada Cachafeiro; Paul Stewart; Joseph J Eron; Susan A Fiscus
Journal:  J Clin Virol       Date:  2009-11-05       Impact factor: 3.168

10.  Development of a microfluidic system for measuring HIV-1 viral load.

Authors:  Shuqi Wang; Alexander Ip; Feng Xu; Francoise F Giguel; Sangjun Moon; Altug Akay; Daniel R Kuritzkes; Utkan Demirci
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.